Table 1. Demographic and baseline characteristics (N = 23).
| Characteristic | Number (percent) | |
|---|---|---|
| Age (yr) | Mean | 62 |
| Range | 44-80 | |
| Sex | Male | 11 (48) |
| Female | 12 (52) | |
| Race | White | 20 (87) |
| Black or African American | 3 (13) | |
| ECOG performance status | 0 | 5 (22) |
| 1 | 13 (57) | |
| 2 | 5 (22) | |
| Study disease at entry | Disease progression during EP chemotherapy | 9 (39) |
| Relapse ≤90 days from previous EP treatment | 11 (48) | |
| SD as best response after at least 2 cycles of EP chemotherapy | 3 (13) | |
| Disease stage | Extensive-stage | 22 (96) |
| Limited-stage | 1 (4) | |
| No. of prior anticancer regimens | Median | 1 |
| Minimum | 1 | |
| Maximum | 3 | |
| Best response to prior therapy | Partial response | 7 (30) |
| Stable disease | 11 (48) | |
| Progressive disease | 2 (9) | |
| Unknown | 3 (13) |